ARRIVENT BIOPHARMA INC (AVBP) Institutional Ownership Changes & 13F Activity
ARRIVENT BIOPHARMA INC (AVBP). Institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC Form 13F filings (Q2 2026). This page analyzes institutional buying and selling activity, new holdings, and sold-out positions in the latest reporting period. Notable filers include Vivo Capital, Llc, Logos Global Management Lp, D. E. Shaw & Co., Inc., Novo Holdings A/S, and Ameriprise Financial Inc.
| Institution | Type | Change in shares | Change Position % | Shares | Reported stock balance | Portfolio quarter | Filing date |
|---|---|---|---|---|---|---|---|
| Manufacturers Life Insurance Company, The | Buy | +1,295 | +14.3% | 10,363 | $360.01K | Q2 2026 | Sep 09, 2026 |
| Citadel Advisors Llc | Sell | -9,415 | -5.7% | 156,742 | $5.45M | Q2 2026 | Sep 02, 2026 |
| Corient Private Wealth Llc | Sell | -6,809 | -25.0% | 20,430 | $709.74K | Q2 2026 | Aug 27, 2026 |
| Optimize Financial Inc | Sell | -65 | -0.3% | 18,851 | $654.88K | Q2 2026 | Aug 27, 2026 |
| California State Teachers Retirement System | Buy | +7,431 | +38.4% | 26,798 | $930.96K | Q2 2026 | Aug 24, 2026 |
| Seven Fleet Capital Management Lp | Buy | +196,354 | +390.7% | 246,606 | $8.57M | Q2 2026 | Aug 17, 2026 |
| Vivo Capital, Llc | Buy | +796,181 | +89.9% | 1,682,097 | $58.44M | Q2 2026 | Aug 14, 2026 |
| Logos Global Management Lp | Buy | +650,000 | +185.7% | 1,000,000 | $34.74M | Q2 2026 | Aug 14, 2026 |
| D. E. Shaw & Co., Inc. | Buy | +503,216 | +136.4% | 872,011 | $30.29M | Q2 2026 | Aug 14, 2026 |
| Novo Holdings A/S | Sell | -442,142 | -22.8% | 1,500,000 | $52.11M | Q2 2026 | Aug 14, 2026 |
| Ameriprise Financial Inc | Buy | +381,589 | — | 381,589 | $13.26M | Q2 2026 | Aug 14, 2026 |
| Foresite Capital Management Vi Llc | Buy | +301,341 | — | 301,341 | $10.47M | Q2 2026 | Aug 14, 2026 |
| Infinitum Asset Management, Llc | Buy | +289,461 | +7.0% | 4,438,384 | $154.19M | Q2 2026 | Aug 14, 2026 |
| Acuta Capital Partners, Llc | Buy | +218,694 | — | 218,694 | $7.60M | Q2 2026 | Aug 14, 2026 |
| Point72 Asset Management, L.P. | Sell | -181,399 | -24.2% | 566,796 | $19.69M | Q2 2026 | Aug 14, 2026 |
| Suvretta Capital Management, Llc | Buy | +114,448 | +2.6% | 4,515,531 | $156.87M | Q2 2026 | Aug 14, 2026 |
| Bank Of America Corp | Buy | +94,658 | +118.0% | 174,866 | $6.07M | Q2 2026 | Aug 14, 2026 |
| Nomura Holdings Inc | Sell | -87,433 | -36.1% | 154,617 | $5.37M | Q2 2026 | Aug 14, 2026 |
| Hrt Financial Lp | Buy | +74,171 | +157.6% | 121,224 | $4.21M | Q2 2026 | Aug 14, 2026 |
| Trexquant Investment Lp | Buy | +71,860 | — | 71,860 | $2.50M | Q2 2026 | Aug 14, 2026 |
| Sectoral Asset Management Inc | Buy | +49,030 | +163.4% | 79,043 | $2.75M | Q2 2026 | Aug 14, 2026 |
| Squarepoint Ops Llc | Sell | -37,888 | -68.4% | 17,544 | $609.48K | Q2 2026 | Aug 14, 2026 |
| Charles Schwab Investment Management Inc | Buy | +35,452 | +13.7% | 294,224 | $10.22M | Q2 2026 | Aug 14, 2026 |
| Invesco Ltd. | Buy | +32,966 | — | 32,966 | $1.15M | Q2 2026 | Aug 14, 2026 |
| Balyasny Asset Management L.P. | Sell | -30,834 | -7.2% | 395,447 | $13.74M | Q2 2026 | Aug 14, 2026 |
| Wells Fargo & Company/Mn | Buy | +24,546 | +202.5% | 36,670 | $1.27M | Q2 2026 | Aug 14, 2026 |
| Wellington Management Group Llp | Buy | +22,642 | +28.9% | 100,855 | $3.50M | Q2 2026 | Aug 14, 2026 |
| Engineers Gate Manager Lp | Buy | +22,259 | — | 22,259 | $773.28K | Q2 2026 | Aug 14, 2026 |
| Alliancebernstein L.P. | Buy | +15,360 | +54.5% | 43,560 | $1.00M | Q2 2026 | Aug 14, 2026 |
| Rafferty Asset Management, Llc | Sell | -12,873 | -34.6% | 24,380 | $846.96K | Q2 2026 | Aug 14, 2026 |
Frequently asked questions about AVBP activity
Which institutional owners are buying AVBP?
Institutional owners buying AVBP include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.
What does "buy" mean in AVBP activity?
"Buy" means an investor increased their reported position in AVBP compared to the prior reporting period. This reflects growing exposure to ARRIVENT BIOPHARMA INC (AVBP) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).
Is institutional interest in AVBP increasing?
Institutional interest in AVBP can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.
Related AVBP Institutional Insights
- AVBP Overview
- AVBP 13F Institutional Holders
- AVBP Top Institutional Shareholders
- Healthcare Sector Institutional Ownership
- Healthcare Sector Portfolio Overlap
- Institutional Portfolio Overlap & Shared Holdings
- Most Bought Healthcare Stocks By Institutional Investors
- Most Sold Healthcare Stocks By Institutional Investors
- AVBP Insider Trading & SEC Form 4 Activity
- AVBP Articles
- Top Institutional Investor Stock Rankings